...
首页> 外文期刊>Rheumatology >Arteriosclerosis obliterans associated with anti-cardiolipin antibody / β2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus
【24h】

Arteriosclerosis obliterans associated with anti-cardiolipin antibody / β2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus

机译:抗心磷脂抗体/β2-糖蛋白I抗体相关的闭塞性动脉硬化是系统性红斑狼疮患者缺血性心脏病的重要危险因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective. The main objective of this study was to clarify the role of aPLs in the pathogenesis of arteriosclerosis obliterans (ASO), ischaemic heart disease (IHD) and cerebral vascular disorder (CVD) in patients with SLE.
机译:目的。这项研究的主要目的是阐明aPL在SLE患者的动脉硬化闭塞症(ASO),缺血性心脏病(IHD)和脑血管疾病(CVD)的发病机理中的作用。

著录项

  • 来源
    《Rheumatology》 |2008年第5期|p.684-689|共6页
  • 作者单位

    1Laboratory for Clinical Investigation, Osaka University Hospital, Suita, Osaka, 2Division of Biomedical Informatics, Course of Health Science, Osaka University Graduate School of Medicine, Suita, 3Department of Health Science, Faculty of Health Science for Welfare, Kansai University of Welfare Science, Kashihara, 4Department of Physiology, Osaka City University Graduate School of Medicine, Abeno-ku and 5Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号